BRPI0409199A - composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico - Google Patents

composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico

Info

Publication number
BRPI0409199A
BRPI0409199A BRPI0409199-0A BRPI0409199A BRPI0409199A BR PI0409199 A BRPI0409199 A BR PI0409199A BR PI0409199 A BRPI0409199 A BR PI0409199A BR PI0409199 A BRPI0409199 A BR PI0409199A
Authority
BR
Brazil
Prior art keywords
prevention
treatment
black rice
rice extract
composition
Prior art date
Application number
BRPI0409199-0A
Other languages
English (en)
Inventor
Jae-Hong Kim
Original Assignee
Cellmics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellmics Co Ltd filed Critical Cellmics Co Ltd
Publication of BRPI0409199A publication Critical patent/BRPI0409199A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçãO PARA A PREVENçãO OU TRATAMENTO DE DOENçAS ALéRGICAS USANDO EXTRATO DE ARROZ PRETO E SEU USO TERAPêUTICO". A presente invenção a uma composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico. Mais precisamente, a presente invenção refere-se a uma composição para a prevenção ou tratamento de doenças alérgicas compreendendo pelargonidina, glicosídeo de cianidina, ou extrato de arroz preto incluindo pelargonidina e glicosídeo de cianidina, que inibe o acúmulo de eosinófilo nos tecidos, como um ingrediente eficaz e um uso terapêutico desta. A pelargonidina, o glicosídeo de cianidina ou o extrato de arroz preto incluindo pelargonidina e glicosídeo de cianidina inibem o acúmulo de eosinófilo nos tecidos e as inflamações alérgicas desse modo, a fim de que eles possam ser eficazmente usados para a prevenção ou tratamento de doenças alérgicas associadas com inflamação e acúmulo de eosinófilo, tais como rinite alérgica, conjuntivite alérgica, asma, doença pulmonar obstrutiva crónica, dermatite atópica e diarréia alérgica, etc.
BRPI0409199-0A 2003-04-04 2004-03-30 composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico BRPI0409199A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20030021476 2003-04-04
PCT/KR2004/000722 WO2004087129A1 (en) 2003-04-04 2004-03-30 Composition for preventing or treating allergic disease using black rice extract and its therapeutic use

Publications (1)

Publication Number Publication Date
BRPI0409199A true BRPI0409199A (pt) 2006-05-02

Family

ID=36273253

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409199-0A BRPI0409199A (pt) 2003-04-04 2004-03-30 composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico

Country Status (10)

Country Link
US (1) US20060147564A1 (pt)
EP (1) EP1617837A4 (pt)
JP (1) JP2006515372A (pt)
KR (1) KR100626850B1 (pt)
CN (1) CN100374111C (pt)
BR (1) BRPI0409199A (pt)
CA (1) CA2520627A1 (pt)
MX (1) MXPA05010400A (pt)
RU (1) RU2313347C2 (pt)
WO (1) WO2004087129A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4717726B2 (ja) * 2006-06-09 2011-07-06 丸善製薬株式会社 花粉アレルゲン不活性化剤、ダニアレルゲン不活性化剤、花粉アレルゲン不活性化材及びダニアレルゲン不活性化材
KR100882505B1 (ko) 2007-05-04 2009-02-06 한국과학기술연구원 아토피성 피부질환 마우스 및 이를 이용한 아토피성피부질환 예방제, 치료제 또는 화장료 조성물의 스크리닝방법
US8784904B2 (en) 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US9610313B2 (en) 2008-04-10 2017-04-04 U.S. Nutraceuticals Eye health composition and method using plant derived seed extract rich in essential fatty acids derived from perilla seed and carotenoids
US8586104B2 (en) 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use
US9770047B2 (en) 2008-04-10 2017-09-26 U.S. Nutraceuticals, LLC Perilla seed composition
KR101648467B1 (ko) * 2009-11-30 2016-08-17 (주)아모레퍼시픽 약용식물 추출물을 함유하여 염증 및 피부 자극을 완화시키는 화장료 조성물
CN102309669B (zh) * 2010-07-08 2013-07-03 高健生 一种治疗变态反应性结膜炎的中药制剂
JP5335018B2 (ja) * 2011-03-04 2013-11-06 丸善製薬株式会社 ダニアレルゲン不活性化剤及びダニアレルゲン不活性化材
KR101517511B1 (ko) * 2013-11-27 2015-05-04 주식회사 파리크라상 페이스트리용 광택제 제조방법
KR101604448B1 (ko) * 2014-05-13 2016-03-21 농업회사법인 잠(유) 흑미미강 추출물을 유효성분으로 함유하는 항염증 및 면역질환 예방 및 치료용 약학 조성물
US11925656B2 (en) 2014-11-05 2024-03-12 Lanny Leo Johnson Biological total joint replacement
US11980635B2 (en) 2014-11-05 2024-05-14 Lanny Leo Johnson Methods of oral administration of protocatechuic acid for treating or reducing the severity of a joint injury or disease
KR101827256B1 (ko) * 2015-05-27 2018-02-09 농업회사법인 잠(유) 흑미 미강 추출 분말의 제조방법 및 그에 따른 흑미 미강 추출 분말
KR101736826B1 (ko) * 2015-05-28 2017-05-18 농업회사법인 잠(유) 흑미미강 추출 분말을 유효성분으로 함유하는 면역기능 향상을 위한 약학 조성물 및 이의 제조방법
KR20150146476A (ko) 2015-12-09 2015-12-31 염다솔 신생혈관생성 억제작용이 있는 흑미추출물 함유 정제코팅제 조성물과 그 용도
KR101839109B1 (ko) * 2016-09-22 2018-03-15 ㈜프론트바이오 퍼플콘 추출물을 함유하는 피부 질환의 예방 또는 치료용 약제학적 조성물
JP7821425B2 (ja) * 2018-03-20 2026-02-27 ウェル ビーイング ゴー カンパニー リミテッド 黒米発芽液の製造方法
KR102106440B1 (ko) * 2018-10-30 2020-05-07 안국건강 주식회사 블루베리 및 흑미 추출물 배양 유산균을 포함하는 피부상태 개선용 조성물
CN109549946B (zh) * 2019-01-08 2020-12-18 牡丹江医学院 一种治疗咽炎的药物及其制备方法
EP3733194A1 (en) * 2019-05-03 2020-11-04 Anklam Extrakt GmbH Maqui berry extracts for treatment of skin diseases
KR102894756B1 (ko) * 2022-10-24 2025-12-03 한국 한의학 연구원 절패모 추출물을 유효성분으로 포함하는 면역증진 및 염증성 장질환의 예방, 개선 또는 치료용 조성물
KR102642230B1 (ko) * 2022-11-24 2024-03-04 (주)에스티알바이오텍 흑미강발효분말 정제분획을 유효성분으로 포함하는 천식 치료용 조성물
CN116898867A (zh) * 2023-08-31 2023-10-20 四川大学 小分子抑制剂在治疗粘液素分泌相关疾病中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925620A (en) * 1990-08-20 1999-07-20 Ohlenschlaeger; Gerhard Therapeutically active mixture of glutathione and anthocyanin compounds
CA2088994C (en) * 1990-08-20 2002-08-13 Gerhard Ohlenschlaeger Therapeutically active mixture of glutathion and anthocyan compounds
JPH06271850A (ja) * 1993-03-23 1994-09-27 Nikken Food Kk 天然物を原料とした抗酸化剤およびその製造方法
CN1055397C (zh) * 1994-07-05 2000-08-16 贝芝芬 一种防治老年病、延缓衰老的保健药酿
CN1105252A (zh) * 1994-07-16 1995-07-19 王平 治疗高血压心脏病的川丸及其制备方法
IT1274699B (it) * 1994-08-02 1997-07-24 Luigi Melis Estratto vegetale contro le ustioni
JP2000032954A (ja) * 1998-07-17 2000-02-02 Gosho:Kk アントシアニン系赤米抽出液・粉末とその製造法
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
KR20060123663A (ko) * 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유하는 조성물
JP2002053468A (ja) 2000-08-11 2002-02-19 Sanei Gen Ffi Inc シアニジン化合物を有効成分とする癌の予防又は治療剤
JP4849734B2 (ja) * 2001-05-15 2012-01-11 三菱化学株式会社 ペラルゴニジン系色素、カロチノイド系色素、またはフィコシアニン系色素とプロアントシアニジンを含有する色素製剤
WO2003074067A1 (en) * 2002-03-01 2003-09-12 Stoner Gary D Compositions of and derived from strawberry and raspberry and therapeutic uses therefor

Also Published As

Publication number Publication date
RU2313347C2 (ru) 2007-12-27
CN1784224A (zh) 2006-06-07
CN100374111C (zh) 2008-03-12
EP1617837A1 (en) 2006-01-25
KR100626850B1 (ko) 2006-09-21
RU2005134229A (ru) 2006-04-27
KR20040086790A (ko) 2004-10-12
EP1617837A4 (en) 2008-08-06
MXPA05010400A (es) 2006-03-21
JP2006515372A (ja) 2006-05-25
US20060147564A1 (en) 2006-07-06
WO2004087129A1 (en) 2004-10-14
CA2520627A1 (en) 2004-10-14

Similar Documents

Publication Publication Date Title
BRPI0409199A (pt) composição para a prevenção ou tratamento de doenças alérgicas usando extrato de arroz preto e seu uso terapêutico
BRPI0516437A (pt) utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
BRPI0416212A (pt) derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BR0317272A (pt) Composições pré-bióticas
BR0013897A (pt) Uso de ácido linoleico conjugado (cla) ou de um seu derivado, composição tópica cosmética ou dermatológica, e, método de tratamento e/ou de profilaxia de celulite e de depósitos de gordura
ATE325612T1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
Ban et al. Korean red ginseng protects against neuronal damage induced by transient focal ischemia in rats
BRPI0606283A2 (pt) formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
JP5540474B2 (ja) 神経伸長抑制剤
BR9912179A (pt) Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão
BRPI0518999A2 (pt) composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
WO2001070737A3 (en) Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof
MD4093B1 (ro) Utilizare a compoziţiei farmaceutice topice cu conţinut de ambroxol
BRPI0408004A (pt) composições e métodos para diagnóstico e tratamento de asma ou outras doenças alérgicas ou inflamatórias
JP2008518974A5 (pt)
CN103027195A (zh) 一种抗球虫的中药饲料添加剂
CN105250465A (zh) 具有止痒作用的瑶药外用洗剂及其制备方法
BR0012408A (pt) Métodos para induzir ou aumentar a migração celular, para reduzir ou inibir a migração celular, para induzir ou aumentar a cura de ferimento em um paciente, e para regular a expressão de pelo menos um gene de uma célula, e, uso de um agonista de fator de tecido
BRPI0511261A (pt) linhagem isolada de lactobacillus sp., uso de uma linhagem isolada de lactobacillus sp., e composição farmacêutica
BR0005010A (pt) Composição para tratamento de distúrbios de secreção externa exceto a hipolacrimação e seu uso
BR0210975A (pt) Composição oral para uso como um agente profilático, terapêutico e/ou cosmético para a obesidade/excesso de peso em mamìferos não diabéticos, inclusive em seres humanos e preparação de uma composição oral
Chen Efficacy of sodium cromoglicate eye drops combined with yupingfeng granules in the treatment of allergic conjunctivitis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/352 (2006.01), A61K 31/353 (2006.01), A61K